Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Shenogen Pharma Group Ltd.
DescriptionSmall molecule targeting estrogen receptor alpha 36 tumor cells
Molecular Target Estrogen receptor alpha 36
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today